Want to see JP:4931 full AI Analyst Report?
4931 Stock Chart & Stats
¥2232.00
¥58.00(3.00%)
At close: 4:00 PM EST
¥2232.00
¥58.00(3.00%)
Day’s Range― - ―
52-Week Range¥1,855.00 - ¥2,386.00
Previous CloseN/A
Volume45.20K
Average Volume (3M)45.53K
Market Cap
¥43.00B
Enterprise Value¥23.02K
Total Cash (Recent Filing)¥18.59B
Total Debt (Recent Filing)¥349.00M
Price to Earnings (P/E)12.9
Beta0.34
Next Earnings
Nov 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.59%
Share Statistics
EPS (TTM)155.54
Shares Outstanding21,855,200
10 Day Avg. Volume64,110
30 Day Avg. Volume45,533
Financial Highlights & Ratios
PEG Ratio-2.68
Price to Book (P/B)2.13
Price to Sales (P/S)1.18
P/FCF Ratio10.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)160.5
Revenue Forecast (FY)¥43.70B
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthExtremely low leverage (debt-to-equity ~0.003) provides durable financial resilience and strategic optionality. Minimal interest burden and a strong equity base support stable dividends, targeted brand investment and potential M&A or capex without stressing liquidity in a downturn.
High Gross MarginsConsistently high gross margins (above ~79%) reflect durable pricing power and efficient sourcing/production in its consumer health and beauty portfolio. A strong gross margin base cushions operating results during revenue softness and supports reinvestment in product development and marketing.
Strong Cash ConversionNear-parity of FCF and operating cash flow to net income (~0.99 and ~0.97) signals high earnings quality and reliable cash generation. This durable cash conversion enables steady shareholder returns and funds working capital, reinvestment and strategic initiatives with limited external financing.
Bears Say
Negative Revenue GrowthA -7.3% revenue decline is a material structural concern: shrinking top line reduces economies of scale, limits marketing and R&D budgets, and makes sustaining brand momentum harder. If revenue erosion persists, long-term growth and market position could be impaired.
Profitability Pressure (net Margin)Net margin falling to ~6.21% indicates bottom-line compression despite strong gross margins, suggesting rising SG&A or non-operating costs. Persistent margin erosion reduces retained earnings and ROE, constraining the company’s ability to reinvest and sustain dividend or growth strategies.
Declining Free Cash Flow GrowthNegative FCF growth in recent years, despite good conversion ratios, signals shrinking absolute cash available for reinvestment. Declining FCF growth can limit capex, marketing spend and shareholder returns over time, weakening the company’s ability to respond to competitive pressures.
Shinnihonseiyaku Co., Ltd. News
4931 FAQ
What was Shinnihonseiyaku Co., Ltd.’s price range in the past 12 months?
Shinnihonseiyaku Co., Ltd. lowest stock price was ¥1855.00 and its highest was ¥2386.00 in the past 12 months.
What is Shinnihonseiyaku Co., Ltd.’s market cap?
Shinnihonseiyaku Co., Ltd.’s market cap is ¥43.00B.
When is Shinnihonseiyaku Co., Ltd.’s upcoming earnings report date?
Shinnihonseiyaku Co., Ltd.’s upcoming earnings report date is Nov 06, 2026 which is in 53 days.
How were Shinnihonseiyaku Co., Ltd.’s earnings last quarter?
Shinnihonseiyaku Co., Ltd. released its earnings results on Aug 07, 2026. The company reported ¥47.17 earnings per share for the quarter.
Is Shinnihonseiyaku Co., Ltd. overvalued?
According to Wall Street analysts Shinnihonseiyaku Co., Ltd.’s price is currently Overvalued.
Does Shinnihonseiyaku Co., Ltd. pay dividends?
Shinnihonseiyaku Co., Ltd. pays a Annually dividend of ¥57 which represents an annual dividend yield of 2.59%. See more information on Shinnihonseiyaku Co., Ltd. dividends here
What is Shinnihonseiyaku Co., Ltd.’s EPS estimate?
Shinnihonseiyaku Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shinnihonseiyaku Co., Ltd. have?
Shinnihonseiyaku Co., Ltd. has 21,855,200 shares outstanding.
What happened to Shinnihonseiyaku Co., Ltd.’s price movement after its last earnings report?
Shinnihonseiyaku Co., Ltd. reported an EPS of ¥47.17 in its last earnings report. Following the earnings report the stock price went up 0.861%.
Which hedge fund is a major shareholder of Shinnihonseiyaku Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4931
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Shinnihonseiyaku Co., Ltd.
Shinnihonseiyaku Co., Ltd. is a Japanese-headquartered company, established in 1992, that specializes in providing cosmetics, pharmaceuticals, and health foods both domestically and in international markets. The company's operations are structured into Mail Order, Direct Store Sales/Wholesale, and Overseas Sales divisions. Its product portfolio includes skincare lines sold under the Perfect One and Perfect One Focus brands, as well as a variety of pharmaceutical products targeting different diseases and symptoms. Shinnihonseiyaku reaches its customers through multiple channels, including eight company-owned retail stores, the NOIN cosmetics mail order application, and various online e-commerce platforms. The firm, previously known as Shinnihonliving Co., Ltd., officially adopted its current name in April 2002, and maintains its corporate headquarters in Fukuoka City.
Technical Analysis
Pharmarise Holdings Corp.
―
COSMOS Pharmaceutical Corporation
―
Yakuodo Holdings Co., Ltd.
―
Chordia Therapeutics Inc.
―
Heartseed, Inc.
―